Evidence map›Paper›PMID 32727092›Full record

ArticleInternational journal of molecular sciences2020

TMARg, a Novel Anthraquinone Isolated from

Kyung-Ran Park, Joon Yeop Lee, Bo-Mi Kim, Sang Wook Kang, Hyung-Mun Yun

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Calycosin-7-O-β-Glucoside Isolated fromInternational journal of molecular sciences · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kyung-Ran ParkDepartment of Oral and Maxillofacial Pathology, School of Dentistry, Kyung Hee University, Seoul 02447, Korea.
Joon Yeop LeeNational Institute for Korean Medicine Development, Gyeongsan 38540, Korea.
Bo-Mi KimNational Institute for Korean Medicine Development, Gyeongsan 38540, Korea.
Sang Wook KangDepartment of Oral and Maxillofacial Pathology, School of Dentistry, Kyung Hee University, Seoul 02447, Korea.
Hyung-Mun YunDepartment of Oral and Maxillofacial Pathology, School of Dentistry, Kyung Hee University, Seoul 02447, Korea.
Kyung Hee University · KRNational Development Institute of Korean Medicine · KR

Funding

National Research Foundation of Korea [NRF] NRF-2018R1D1A1B07043282
6 · The paper itself

Abstract

backgroundPlant extracts have long been regarded as useful medicines in the treatment of human diseases.

methodsCell viability was evaluated using an MTT assay. Early and late osteoblast differentiation was examined by analyzing the activity of alkaline phosphatase (ALP), and by staining it with Alizarin red S (ARS). Cell migration was determined by using migration assays. Western blot analysis and immunocytochemical analysis were used to examine the intracellular signaling pathways and differentiation proteins.

resultsIn the present study, TMARg showed no cytotoxicity and increased the osteoblast differentiation in pre-osteoblasts, as assessed from the alkaline phosphate (ALP) staining and activity and ARS staining. TMARg also induced BMP2 expression and increased the p-smad1/5/8-RUNX2 and β-catenin pathways in both MC3T3-E1 and C2C12 cells. Furthermore, TMARg activated mitogen-activated protein kinases (MAPKs) and increased the cell migration rate. In addition, the TMARg-mediated osteoblast differentiation was suppressed by BMP and Wnt inhibitors with the downregulation of BMP2 expression.

conclusionThese findings demonstrate that TMARg exerts pharmacological and biological effects on osteoblast differentiation through the activation of BMP2 and β-catenin signaling pathways, and suggest that TMARg might be a potential phytomedicine for the treatment of bone diseases.

Indexed as

AnimalsAnthraquinonesbeta CateninBone Morphogenetic Protein 2Calcification, PhysiologicCell LineMiceOsteoblastsOsteogenesisPlant BarkRubiaSignal TransductionAnthraquinonesbeta CateninBmp2 protein, mouseBone Morphogenetic Protein 2CTNNB1 protein, mouseBMP2osteoblastphytomedicineRubia cordifolia NakaiTMARgβ-catenin

Identifiers

PMID32727092
PMCPMC7432489
OpenAlexW3044150510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.